Search

everythinglearnresearchcommunity

for

Search:↓

TNF-α blockers and IL inhibitors improve symptoms in most patients with severe scalp condition, but more research is needed.

JAK-inhibitors for alopecia areata are generally safe with mostly mild side effects and a low rate of treatment withdrawal.

Tofacitinib helped psoriasis but not alopecia universalis, needing more research.

Certolizumab effectively treats psoriasis and psoriatic arthritis with fewer side effects than adalimumab.

Tofacitinib was effective for severe, treatment-resistant hair loss without side effects.

These new skin treatments are safer and more effective with minimal side effects.

Upadacitinib may effectively treat resistant lichen planopilaris.

Oral tofacitinib effectively treats alopecia areata long-term with manageable side effects.

Tofacitinib effectively reduces hair loss in children with alopecia areata but may cause mild side effects and relapses.

The hydrogel dressing speeds up and improves diabetic wound healing.

Baricitinib helps treat several diseases, including COVID-19, but has side effects and needs careful monitoring.

Effective immunomodulatory treatments and a personalized approach are crucial for managing severe folliculitis decalvans.

Tofacitinib may be effective for treating hair loss caused by alopecia areata that doesn't respond to other treatments.

Tofacitinib may help treat Lichen Planopilaris, but more research is needed.

Posaconazole is a promising new treatment for toenail fungus.

An arthritis drug helped a person with severe hair loss regrow their hair.

Diphenylcyclopropenone (DPCP) effectively treated both alopecia areata and verruca vulgaris.

Dipotassium glycyrrhizinate helps wounds heal faster, especially in the early stages.

Oral ritlecitinib and baricitinib are promising treatments for severe alopecia areata due to their balance of effectiveness and safety.

Topical cyclosporin-A is recommended for severe alopecia areata.

The new wound dressing with minoxidil and dexamethasone could speed up healing and reduce scarring in rats.

Low-dose methotrexate is generally safe but can cause mild to severe side effects, and folic acid can reduce these risks.

Cyclosporine-A can cause serious blood clots in the brain, so patients need careful monitoring.